"AskHER",
a survey on
recurrence risk perceptions in
women with HER2+ breast cancer
France, Germany, Italy, Portugal, Spain, Sweden • 2022-2023
The results of the AskHER2 survey show that there is still room for improvement in patient awareness of the individual risk of recurrence, and that patients are willing to make lifestyle changes to improve disease management.
622
patients
21%
were unaware of their personal risk of recurrence
30%
considered the doctors' communication to be clear
97%
wanted to be involved in treatment decisions